Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders
J. C. Byrd, M. R. Grever, J. K. Waselenko, C. R. Willis, K. Park, A. Goodrich, M. A. Lucas, C. Shinn, I. W. Flinn
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders'. Together they form a unique fingerprint.